论文部分内容阅读
目的:探究在小儿肺炎治疗时,使用雾化吸入盐酸氨溴索辅助治疗的效果。方法:针对40例小儿肺炎患者实施常规治疗,并归为对照组,针对另外40例患者在对照组基础上进行雾化吸入盐酸氨溴索辅助治疗,并归为观察组,比较两组患者临床情况并比较其效果。结果:比较两组治疗的总有效率,明显可见观察组患者较高,P<0.05则说明差异明显。两组不良反应发生率均为5.0%,故不存在明显差异。结论:雾化吸入盐酸氨溴索辅助治疗小儿肺炎具有较好的临床效果,提高有效率的同时不会增加不良反应,因此具有辅助治疗的可行性,故值得临床优先选择使用。
Objective: To explore the effect of using ambroxol hydrochloride ambroxol in the treatment of pediatric pneumonia. Methods: 40 cases of children with pneumonia were treated with routine treatment and classified as control group. Another 40 patients were treated with atomization inhalation of ambroxol hydrochloride on the basis of the control group, and were assigned to the observation group. The clinical data of two groups were compared Situation and compare its effect. Results: Comparing the total effective rate of the two groups, obviously the patients in the observation group were higher, P <0.05, the difference was obvious. Adverse reactions in both groups were 5.0%, so there is no significant difference. CONCLUSION: Ambroxol hydrochloride is an effective adjuvant therapy for children with pneumonia. It is effective in adjuvant treatment because of its good clinical effect, high efficiency and no adverse reactions. Therefore, it is worthy of clinical preference.